-
ViroMed Secures DNA Production Facility in the US
americanpharmaceuticalreview
August 21, 2018
ViroMed announced the acquisition of a plasmid DNA production facility in San Diego, California from Vical Incorporated. With ViroMed's first Phase III clinical trial of its lead product VM202 (donaperminogene seltoplasmid) for painful diabetic peripheral
-
Merck, HitGen expand DNA library screening collaboration
fiercebiotech
August 07, 2018
Merck and HitGen have upsized their licensing agreement into a full-fledged, multiyear drug discovery collaboration, with plans to screen DNA-encoded libraries for new small-molecule assets.
-
Applied DNA reaches new milestones
biospectrumasia
August 03, 2018
In the past 12 months, Applied DNA has shipped over 8,000 milligrams of PCR-produced linear DNA for use in Diagnostic and Therapeutic applications.
-
Abivax drug lowers HIV DNA in blood and tissue, but has the opposite effect for some
pharmafile
July 06, 2018
Biotechnology firm Abivax has lifted the curtain on new Phase 2a data for its HIV therapy ABX464, showing that the drug was able to reduce levels of the virus’ DNA in blood and rectal tissue.
-
DNA test may detect liver cancer
europeanpharmaceuticalreview
June 08, 2018
A group of researchers have completed a phase II study comparing a set of DNA markers to alpha-fetoprotein as a method to test for liver cancer….
-
Web tool predicts phenotypes from a DNA sample
europeanpharmaceuticalreview
May 22, 2018
An international team of scientists have developed a novel tool to accurately predict eye, hair and skin colour from human biological material…
-
Genoox Collaborates with Bionano to Enhance the Detection of Disease Causing Structural Variants in DNA
biospace
April 16, 2018
Genoox, announced a collaboration today with Bionano Genomics a company that offers optical mapping to better understand the genome and its structure.
-
Programming DNA to deliver cancer drugs
europeanpharmaceuticalreview
March 26, 2018
New technology could lead to the development of new cancer therapies…
-
Oxford Nanopore raises $140 M led by Asian investors
biospectrumasia
March 23, 2018
This expanded range is designed to address all parts of the existing DNA-sequencing market, as well as enabling new applications that can only be performed with a real-time, scalable, long-read technology.
-
New Study Indicates DNA Plays Role in Gender Identity
biospace
March 20, 2018
In the world of politics and civil rights, the ideas of gender and transgender have been a hot-button issue.